TASK-3 as a potential antidepressant target

Brain Research

Volumn 1416, Issue , 2011, Pages 69-79

  Gotter, Anthony L ^a   Santarelli, Vincent P ^a   Doran, Scott M ^a   Tannenbaum, Pamela L ^a   Kraus, Richard L ^a   Rosahl, Thomas W ^a   Meziane, Hamid ^b   Montial, Marina ^b   Reiss, Duane R ^a   Wessner, Keith ^a   McCampbell, Alexander ^a   Stevens, Joanne ^a   Brunner, Joseph I ^a   Fox, Steven V ^a   Uebele, Victor N ^a   Bayliss, Douglas A ^c   Winrow, Christopher J ^a   Renger, John J ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b INSTITUT CLINIQUE DE LA SOURIS   (France)

^c UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Circadian; Kcnk9; Major depressive disorder; Polysomnography; Sleep; TASK 3

Indexed keywords

FLUOXETINE; MUTANT PROTEIN; POTASSIUM CHANNEL; PROTEIN TASK 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AROUSAL; ARTICLE; BODY TEMPERATURE; CIRCADIAN RHYTHM; COGNITION; CONTROLLED STUDY; DRUG TARGETING; ELECTROENCEPHALOGRAM; EXPERIMENTAL TEST; FORCED SWIMMING TEST; IMMOBILIZATION; KNOCKOUT MOUSE; LOCOMOTION; MALE; MOOD DISORDER; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP; SLOW WAVE SLEEP; TAIL SUSPENSION TEST; THALAMOCORTICAL TRACT; THALAMUS NUCLEUS; WILD TYPE;

ANIMALIA; MUS;

EID: 80052963048     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.08.021     Document Type: Article

References (46)

1. M. Angles-Pujolras, A. Diez-Noguera, V. Soria, M. Urretavizcaya, J.M. Menchon, and T. Cambras Electroconvulsive shock alters the rat overt rhythms of motor activity and temperature without altering the circadian pacemaker Behav. Brain Res. 196 2009 37 43
2. O. Barel, S.A. Shalev, R. Ofir, A. Cohen, J. Zlotogora, Z. Shorer, G. Mazor, G. Finer, S. Khateeb, N. Zilberberg, and O.S. Birk Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9 Am. J. Hum. Genet. 83 2008 193 199
3. D.A. Bayliss, E.M. Talley, J.E. Sirois, and Q. Lei TASK-1 is a highly modulated pH-sensitive 'leak' K(+) channel expressed in brainstem respiratory neurons Respir. Physiol. 129 2001 159 174 (Pubitemid 33103925)
4. A.A. Borbely, I. Tobler, M. Loepfe, D.J. Kupfer, R.F. Ulrich, V. Grochocinski, J. Doman, and G. Matthews All-night spectral analysis of the sleep EEG in untreated depressives and normal controls Psychiatry Res. 12 1984 27 33 (Pubitemid 14111956)
5. K.J. Buckler, B.A. Williams, and E. Honore An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells J. Physiol. 525 Pt 1 2000 135 142 (Pubitemid 30311941)
6. W.A. Coetzee, Y. Amarillo, J. Chiu, A. Chow, D. Lau, T. McCormack, H. Moreno, M.S. Nadal, A. Ozaita, D. Pountney, M. Saganich, d.M. Vega-Saenz, and B. Rudy Molecular diversity of K+ channels Ann. N. Y. Acad. Sci. 868 1999 233 285
7. P.Y. Deng, and S. Lei Serotonin increases GABA release in rat entorhinal cortex by inhibiting interneuron TASK-3 K+ channels Mol. Cell. Neurosci. 39 2008 273 284
8. D.G. Dillon, R. Bogdan, J. Fagerness, A.J. Holmes, R.H. Perlis, and D.A. Pizzagalli Variation in TREK1 gene linked to depression-resistant phenotype is associated with potentiated neural responses to rewards in humans Hum. Brain Mapp. 31 2010 210 221
9. C. Dugovic, S. Maccari, L. Weibel, F.W. Turek, and O. Van Reeth High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations J. Neurosci. 19 1999 8656 8664 (Pubitemid 30226784)
10. C. Dugovic, L.C. Solberg, E. Redei, O. Van Reeth, and F.W. Turek Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression Neuroreport 11 2000 627 631 (Pubitemid 30120488)
11. F. Duprat, F. Lesage, M. Fink, R. Reyes, C. Heurteaux, and M. Lazdunski TASK, a human background K+ channel to sense external pH variations near physiological pH EMBO J. 16 1997 5464 5471 (Pubitemid 27380153)
12. F. Duval, B.D. Lebowitz, and J.P. Macher Treatments in depression Dialogues Clin. Neurosci. 8 2006 191 206 (Pubitemid 44113990)
13. M. El Yacoubi, S. Bouali, D. Popa, L. Naudon, I. Leroux-Nicollet, M. Hamon, J. Costentin, J. Adrien, and J.M. Vaugeois Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression Proc. Natl. Acad. Sci. U. S. A. 100 2003 6227 6232 (Pubitemid 36576958)
14. D.E. Ford, and D.B. Kamerow Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA 262 1989 1479 1484 (Pubitemid 19220042)
15. S.A. Goldstein, D. Bockenhauer, I. O'Kelly, and N. Zilberberg Potassium leak channels and the KCNK family of two-P-domain subunits Nat. Rev. Neurosci. 2 2001 175 184 (Pubitemid 33673370)
16. L. Grunhaus, J.E. Shipley, A. Eiser, A.C. Pande, R. Tandon, D.D. Krahn, M.A. Demitrack, A. Remen, S. Hirschmann, and J.F. Greden Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy Biol. Psychiatry 42 1997 191 200 (Pubitemid 27330562)
17. C. Heurteaux, G. Lucas, N. Guy, M. El Yacoubi, S. Thummler, X.D. Peng, F. Noble, N. Blondeau, C. Widmann, M. Borsotto, G. Gobbi, J.M. Vaugeois, G. Debonnel, and M. Lazdunski Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype Nat. Neurosci. 9 2006 1134 1141 (Pubitemid 44306306)
18. E. Honore The neuronal background K2P channels: focus on TREK1 Nat. Rev. Neurosci. 8 2007 251 261 (Pubitemid 46452327)
19. L.E. Kennard, J.R. Chumbley, K.M. Ranatunga, S.J. Armstrong, E.L. Veale, and A. Mathie Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine Br. J. Pharmacol. 144 2005 821 829 (Pubitemid 40516121)
20. R.L. Kraus, Y. Li, Y. Gregan, A.L. Gotter, V.N. Uebele, S.V. Fox, S.M. Doran, J.C. Barrow, Z.Q. Yang, T.S. Reger, K.S. Koblan, and J.J. Renger In vitro characterization of T-type calcium channel antagonist TTA-A2 and in vivo effects on arousal in mice J. Pharmacol. Exp. Ther. 335 2010 409 417
21. D.J. Kupfer, C.F. Reynolds III, R.F. Ulrich, and V.J. Grochocinski Comparison of automated REM and slow-wave sleep analysis in young and middle-aged depressed subjects Biol. Psychiatry 21 1986 189 200 (Pubitemid 16040347)
22. F. Lesage Pharmacology of neuronal background potassium channels Neuropharmacology 44 2003 1 7 (Pubitemid 36135836)
23. A.M. Linden, C. Sandu, M.I. Aller, O.Y. Vekovischeva, P.H. Rosenberg, W. Wisden, and E.R. Korpi TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics J. Pharmacol. Exp. Ther. 323 2007 924 934 (Pubitemid 350146069)
24. Y.J. Liou, T.J. Chen, S.J. Tsai, Y.W. Yu, C.Y. Cheng, and C.J. Hong Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment Pharmacogenet. Genomics 19 2009 735 741
25. H.J. Meadows, and A.D. Randall Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel Neuropharmacology 40 2001 551 559 (Pubitemid 32209040)
26. S.G. Meuth, T. Budde, T. Kanyshkova, T. Broicher, T. Munsch, and H.C. Pape Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons J. Neurosci. 23 2003 6460 6469 (Pubitemid 36909871)
27. D.K. Mulkey, E.M. Talley, R.L. Stornetta, A.R. Siegel, G.H. West, X. Chen, N. Sen, A.M. Mistry, P.G. Guyenet, and D.A. Bayliss TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity J. Neurosci. 27 2007 14049 14058 (Pubitemid 351377868)
28. D.S. Pang, C.J. Robledo, D.R. Carr, T.C. Gent, A.L. Vyssotski, A. Caley, A.Y. Zecharia, W. Wisden, S.G. Brickley, and N.P. Franks An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action Proc. Natl. Acad. Sci. U.S.A. 106 2009 17546 17551
29. R.H. Pastel, and J.D. Fernstrom Short-term effects of fluoxetine and trifluoromethylphenylpiperazine on electroencephalographic sleep in the rat Brain Res. 436 1987 92 102 (Pubitemid 17167139)
30. A.J. Patel, E. Honore, F. Lesage, M. Fink, G. Romey, and M. Lazdunski Inhalational anesthetics activate two-pore-domain background K+ channels Nat. Neurosci. 2 1999 422 426 (Pubitemid 30491251)
31. R.H. Perlis, P. Moorjani, J. Fagerness, S. Purcell, M.H. Trivedi, M. Fava, A.J. Rush, and J.W. Smoller Pharmacogenetic analysis of genes implicated in rodent models of antidepressant response: association of TREK1 and treatment resistance in the STAR(*)D study Neuropsychopharmacology 33 2008 2810 2819
32. J.C. Pinheiro, and D.M. Bates Mixed-Effects Models in S and S-Plus 2002 Springer New York, New York
33. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch. Int. Pharmacodyn. Ther. 229 1977 327 336 (Pubitemid 8225714)
34. J.J. Renger, S.L. Dunn, S.L. Motzel, C. Johnson, and K.S. Koblan Sub-chronic administration of zolpidem affects modifications to rat sleep architecture Brain Res. 1010 2004 45 54 (Pubitemid 38569851)
35. D. Riemann, and M. Berger The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder Acta Psychiatr. Scand. 81 1990 24 31 (Pubitemid 20096984)
36. R.T. Rubin, E.K. Heist, S.S. McGeoy, K. Hanada, and I.M. Lesser Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects Arch. Gen. Psychiatry 49 1992 558 567
37. I.H. Slater, G.T. Jones, and R.A. Moore Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake Neuropharmacology 17 1978 383 389 (Pubitemid 8356964)
38. A. Steiger, and M. Kimura Wake and sleep EEG provide biomarkers in depression J. Psychiatr. Res. 44 2010 242 252
39. M.P. Szuba, B.H. Guze, and L.R. Baxter Jr. Electroconvulsive therapy increases circadian amplitude and lowers core body temperature in depressed subjects Biol. Psychiatry 42 1997 1130 1137 (Pubitemid 28049925)
40. E.M. Talley, and D.A. Bayliss Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action J. Biol. Chem. 277 2002 17733 17742 (Pubitemid 34967579)
41. E.M. Talley, G. Solorzano, Q. Lei, D. Kim, and D.A. Bayliss Cns distribution of members of the two-pore-domain (KCNK) potassium channel family J. Neurosci. 21 2001 7491 7505 (Pubitemid 32904948)
42. C. Touma, T. Fenzl, J. Ruschel, R. Palme, F. Holsboer, M. Kimura, and R. Landgraf Rhythmicity in mice selected for extremes in stress reactivity: behavioural, endocrine and sleep changes resembling endophenotypes of major depression PLoS One 4 2009 e4325
43. G.W. Vogel, A. Thurmond, P. Gibbons, K. Sloan, and M. Walker REM sleep reduction effects on depression syndromes Arch. Gen. Psychiatry 32 1975 765 777
44. C.P. Washburn, J.E. Sirois, E.M. Talley, P.G. Guyenet, and D.A. Bayliss Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance J. Neurosci. 22 2002 1256 1265 (Pubitemid 34163727)
45. C.J. Winrow, A.L. Gotter, C.D. Cox, S.M. Doran, P.L. Tannenbaum, M.J. Breslin, S.L. Garson, S.V. Fox, C.M. Harrell, J. Stevens, D.R. Reiss, D. Cui, P.J. Coleman, and J.J. Renger Promotion of sleep by suvorexant-a novel dual orexin receptor antagonist J. Neurogenet. 25 2011 52 61
46. A. Wirz-Justice Biological rhythm disturbances in mood disorders Int. Clin. Psychopharmacol. 21 Suppl. 1 2006 S11 S15